Thomas J. Lomis

453 total citations
13 papers, 319 citations indexed

About

Thomas J. Lomis is a scholar working on Oncology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Thomas J. Lomis has authored 13 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Organic Chemistry and 4 papers in Cancer Research. Recurrent topics in Thomas J. Lomis's work include Metal complexes synthesis and properties (5 papers), Breast Cancer Treatment Studies (4 papers) and Ferrocene Chemistry and Applications (2 papers). Thomas J. Lomis is often cited by papers focused on Metal complexes synthesis and properties (5 papers), Breast Cancer Treatment Studies (4 papers) and Ferrocene Chemistry and Applications (2 papers). Thomas J. Lomis collaborates with scholars based in United States, Czechia and United Kingdom. Thomas J. Lomis's co-authors include Kristin A. Skinner, Melvin J. Silverstein, Rex E. Shepherd⊛, Richard R. Koepsel, Barbara D. Florentine, Howard Silberman, Darcy Spicer, Silvia C. Formenti, Jehangir Mistry and Rashmi S. Hegde and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Biochemical Journal.

In The Last Decade

Thomas J. Lomis

11 papers receiving 302 citations

Peers

Countries citing papers authored by Thomas J. Lomis

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Lomis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Lomis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Lomis more than expected).

Fields of papers citing papers by Thomas J. Lomis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Lomis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Lomis. The network helps show where Thomas J. Lomis may publish in the future.

Co-authorship network of co-authors of Thomas J. Lomis

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Lomis. A scholar is included among the top collaborators of Thomas J. Lomis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Lomis. Thomas J. Lomis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Structural biomarkers for breast cancer determined by x-ray diffraction 2024 ·Jonathan M. Friedman, (unknown), (unknown), (unknown), А. Ф. Лазарев, Wei Zhang, (unknown), (unknown), Thomas J. Lomis, (unknown), (unknown)	3
2	TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early-stage breast cancer. 2022 ·Journal of Clinical Oncology ·Sara A. Hurvitz, (unknown), David W. Chan, (unknown), Thomas J. Lomis, Nicholas P. McAndrew, Laura M. Spring, Merry Tetef, (unknown), Steven Applebaum, (unknown), Shaker R. Dakhil, Brian DiCarlo, (unknown), (unknown), William Lawler, (unknown), Christine Kivork, (unknown), Aditya Bardia	21
3	Abstract PS14-11: Differential gene expression analysis and clinical utility of MammaPrint and BluePrint in male breast cancer patients 2021 ·Cancer Research ·Jennifer A. Crozier, (unknown), Kalyan Banda, (unknown), (unknown), Sami Diab, Ian Grady, Thomas J. Lomis, Charles Cox, (unknown), Benjamin Nota, Andrea Menicucci, (unknown), William Audeh, (unknown)	1
4	Abstract OT1-13-01: MammaPrint, BluePrint, and full-genome data linked with clinical data to evaluate new gene expression profiles (FLEX) 2019 ·Cancer Research ·Adam Brufsky, (unknown), Ian Grady, Thomas J. Lomis, Pat W. Whitworth, (unknown), Gordan Srkalović, (unknown), Peter Blumencranz, Paul L. Baron, Blanche H. Mavromatis, (unknown), (unknown), (unknown), William Audeh, (unknown)	0
5	Predicting Axillary Nodal Positivity in 2282 Patients with Breast Carcinoma 2001 ·World Journal of Surgery ·Melvin J. Silverstein, Kristin A. Skinner, Thomas J. Lomis	182
6	Preoperative Paclitaxel and Radiotherapy for Locally Advanced Breast Cancer: Surgical Aspects 2000 ·Annals of Surgical Oncology ·Kristin A. Skinner, Howard Silberman, Barbara D. Florentine, Thomas J. Lomis, (unknown), Darcy Spicer, Silvia C. Formenti	27
7	First place winner of the Conrad Jobst Award in the gold medal paper competition. Nitric oxide synthase inhibitors N-monomethylarginine and aminoguanidine prevent the progressive and severe hypotension associated with a rat model of pancreatitis. 1995 ·PubMed ·Thomas J. Lomis, (unknown), (unknown), (unknown), (unknown), (unknown), Alan B. McMillan, (unknown), Charles J. Lowenstein, (unknown)	30
8	A ferryl(V) pathway in DNA cleavage induced by Fe II (haph) with O2 or H2O2 1992 ·Journal of the Chemical Society Chemical Communications ·Rex E. Shepherd⊛, Thomas J. Lomis, Richard R. Koepsel	6
9	Structural studies on the inactivation of γ-glutamylcysteine synthetase by the disulphide analogues of radioprotective cysteamine derivatives. Effects of aminoalkyl and hydroxyalkyl chain length and ββ-bis-dimethylation 1990 ·Biochemical Journal ·Nina F. Schor, (unknown), Thomas J. Lomis, (unknown)	8
10	The crystal structure of [Cu(HAPH)]ClO4·1.6H2O and the cleavage of DNA by analogs of the metal binding core of bleomycin 1990 ·Inorganica Chimica Acta ·Rex E. Shepherd⊛, Thomas J. Lomis, Richard R. Koepsel, Rashmi S. Hegde, Jehangir Mistry	14
11	Effect of a thio group on simplified analogs of bleomycin 1989 ·Inorganica Chimica Acta ·Thomas J. Lomis, Jennifer Martin, (unknown), Songsheng Zhang, (unknown), Rex E. Shepherd⊛, (unknown)	4
12	Iron(II) and copper(II) complexes of N-(2-(imidazol-3-yl)ethyl-6-(((2-(imidazol-3-yl)ethyl)amino)methyl)-2-pyridinecarboxamide, a bleomycin metal binding site analog with apical imidazole coordination 1989 ·Inorganic Chemistry ·Thomas J. Lomis, Michael Elliott, (unknown), (unknown), Richard R. Koepsel, Rex E. Shepherd⊛	11
13	Bleomycin metal site models with apical imidazole or sulphydryl donors 1988 ·Journal of the Chemical Society Chemical Communications ·Thomas J. Lomis, (unknown), Rex E. Shepherd⊛	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact